Skip to content
healthcare.dev
Get a free key

GOODNOW ALLERGY RELIEF

NDC 82501-0422, Cetirizine Hydrochloride, tablet, film coated, from Gobrands, Inc.

Product NDC
82501-0422
Status
Listed
Labeler
Gobrands, Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078336
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82501-0422 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
82501-0422-1825010422011 BOTTLE in 1 CARTON (82501-0422-1) / 30 TABLET, FILM COATED in 1 BOTTLE (82501-0422-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82501-0422 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82501-0422 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82501-0422. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.